Search alternatives:
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
step decrease » sizes decrease (Expand Search), we decrease (Expand Search)
nn decrease » _ decrease (Expand Search), mean decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1601
One-step synthesis of magnetic-TiO<sub>2</sub>-nanocomposites with high iron oxide-composing ratio for photocatalysis of rhodamine 6G
Published 2019“…With the same composing ratio of 0.5 and 0.35 (Fe:Ti, mole:mole), we prepared two types of magnetic-TiO<sub>2</sub>-nanocomposites as one-step synthesized Fe<sub>x</sub>O<sub>y</sub>-composed TiO<sub>2</sub> (Fe<sub>x</sub>O<sub>y</sub>/TiO<sub>2</sub>-0.5 and Fe<sub>x</sub>O<sub>y</sub>/TiO<sub>2</sub>-0.35) and two-step synthesized core-shell Fe<sub>x</sub>O<sub>y</sub>@TiO<sub>2</sub> (Fe<sub>x</sub>O<sub>y</sub>@TiO<sub>2</sub>-0.5 and Fe<sub>x</sub>O<sub>y</sub>@TiO<sub>2</sub>-0.35), and tested their performance in rhodamine 6G (R6G) photodegradation. …”
-
1602
Table1_Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.docx
Published 2024“…</p>Results<p>16 patients discontinued their afterload-reducing drugs, resulting in a significant decrease in median LVOT gradient from 86.5 [60.5–109.3] mmHg to 61.5 [28.3–97.50] mmHg (p = 0.0004). …”
-
1603
Table1_Discontinuation of afterload-reducing drugs decreases left ventricular outflow tract obstruction in hypertrophic obstructive cardiomyopathy.docx
Published 2024“…</p>Results<p>16 patients discontinued their afterload-reducing drugs, resulting in a significant decrease in median LVOT gradient from 86.5 [60.5–109.3] mmHg to 61.5 [28.3–97.50] mmHg (p = 0.0004). …”
-
1604
-
1605
-
1606
Summary of the gradual disappearance of the peaks with decreasing DMSO-d6 concentrations.
Published 2012“…<p>(<b>A</b>) <sup>1</sup>H-<sup>15</sup>N HSQC spectra of GED in 100%, 90%, 85%, 80%, 70% and 50% DMSO-d6 at 45°C, as marked in the left hand panel within the spectra. …”
-
1607
-
1608
-
1609
-
1610
-
1611
-
1612
-
1613
-
1614
-
1615
DataSheet_1_Hemizygous nonsense variant in the moesin gene (MSN) leads to a new autoimmune phenotype of Immunodeficiency 50.pdf
Published 2022“…Whole exome sequencing identified a previously not described hemizygous nonsense variant (c.650G>A, p.W217X) within exon 6 of the moesin (MSN) gene localized on chromosome X, resulting in significantly decreased MSN mRNA expression compared to healthy controls. …”
-
1616
-
1617
Decreased spacing with different numbers of branches to enhance green fig production
Published 2023“…The spacing of 0.50 m decreases production per plant, but increases yield in 73%. …”
-
1618
Brivanib decreases viability of PDGF-BB treated LX-2 cells.
Published 2014“…Cells showed a brivanib dose-dependent decrease in viability, with half maximal inhibitory concentration (IC<sub>50</sub>) of 16.98 µM (95% CI 13.95 µM–20.67 µM). …”
-
1619
Table_2_Move for Life an intervention for inactive adults aged 50 years and older: a cluster randomised feasibility trial.DOCX
Published 2024“…Background<p>Move for Life (MFL) is a theory-informed intervention that was developed to augment established physical activity (PA) programmes and enable inactive adults aged 50 years and older to be more active. …”
-
1620
Table_1_Move for Life an intervention for inactive adults aged 50 years and older: a cluster randomised feasibility trial.DOCX
Published 2024“…Background<p>Move for Life (MFL) is a theory-informed intervention that was developed to augment established physical activity (PA) programmes and enable inactive adults aged 50 years and older to be more active. …”